Ohcanbohtosat - Matthew Zapf
- Čájehuvvo 1 - 4 / 4
-
1
Novel clinical therapeutics targeting the epithelial to mesenchymal transition Dahkki Anai N. Kothari, Zhiyong Mi, Matthew Zapf, Paul C. Kuo
Almmustuhtton 2014Revisão -
2
-
3
Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis Dahkki Matthew Arffa, Matthew Zapf, Anai N. Kothari, Victor Chang, Gopal N. Gupta, Xianzhong Ding, Mohammed M.H. Al-Gayyar, Wing‐Kin Syn, Nehal M. Elsherbiny, Paul C. Kuo, Zhenghui Mi
Almmustuhtton 2016Artigo -
4
Osteopontin mediates an MZF1–TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer Dahkki C. Weber, Anai N. Kothari, Philip Y. Wai, Neill Y. Li, Joseph Driver, Matthew Zapf, Carrie A. Franzen, Gopal N. Gupta, Clodia Osipo, Andrei Zlobin, Wing‐Kin Syn, Jinhua Zhang, P.C. Kuo, Zhenghui Mi
Almmustuhtton 2014Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Cancer research
Medicine
Cancer
Cell biology
Immunology
Internal medicine
Metastasis
Osteopontin
Pathology
Tumor microenvironment
Biochemistry
Bioinformatics
Biotechnology
CD44
Cancer cell
Cancer stem cell
Carcinogenesis
Cell
Chemistry
Cholecystectomy
Clinical trial
Computational biology
Confidence interval
Disease
Downregulation and upregulation
Drug
Drug development
Economic growth
Economics